Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data

21 May 2014

Abstract excerpt

A third of patients with epithelial ovarian cancer (OVCA) will not respond to standard treatment. The determination of a robust signature that predicts chemoresponse could lead to the identification of molecular markers for response as well as possible clinical implementation in the future to identify patients at risk of failing therapy. This pilot study was designed to identify biologic processes affecting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ovarian cancer diagnosis and treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24848511
DOI: 10.1158/0008-5472.can-14-0186

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput DataPMID 24848511Read ↗

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.Semantic proximity Read ↗

Prediction of chemo-response in serous ovarian cancerSemantic proximity Read ↗

Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian CancerSemantic proximity Read ↗

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical OutcomeSemantic proximity Read ↗

Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.Semantic proximity Read ↗

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA SequencingSemantic proximity Read ↗

Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategiesSemantic proximity Read ↗

Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratificationSemantic proximity Read ↗

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentSemantic proximity Read ↗

The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 studySemantic proximity Read ↗

Integrated analysis of scRNA-seq and bulk RNA-seq identifies FBXO2 as a candidate biomarker associated with chemoresistance in HGSOCSemantic proximity Read ↗

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.